nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Adenosine triphosphate—ACVRL1—hypertension	0.00282	0.178	CrCbGaD
Regadenoson—S-Adenosylmethionine—CBS—hypertension	0.00223	0.14	CrCbGaD
Regadenoson—Nelarabine—ADA—hypertension	0.00176	0.111	CrCbGaD
Regadenoson—Vidarabine—ADA—hypertension	0.00166	0.105	CrCbGaD
Regadenoson—Adenosine—ADA—hypertension	0.00133	0.0838	CrCbGaD
Regadenoson—Adenosine—ADORA1—hypertension	0.00126	0.0794	CrCbGaD
Regadenoson—Adenosine triphosphate—ADRBK1—hypertension	0.00117	0.0737	CrCbGaD
Regadenoson—Adenosine triphosphate—ABCC9—hypertension	0.00117	0.0737	CrCbGaD
Regadenoson—S-Adenosylmethionine—COMT—hypertension	0.000672	0.0423	CrCbGaD
Regadenoson—Adenosine monophosphate—PDE4D—hypertension	0.000655	0.0412	CrCbGaD
Regadenoson—Adenosine triphosphate—AKT1—hypertension	0.000581	0.0366	CrCbGaD
Regadenoson—Adenosine monophosphate—SRC—hypertension	0.000572	0.036	CrCbGaD
Regadenoson—ADORA2A—Signaling by GPCR—TAC1—hypertension	0.000139	0.000532	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADORA1—hypertension	0.000137	0.000527	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—BDKRB2—hypertension	0.000137	0.000525	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ANXA1—hypertension	0.000136	0.000522	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCR3—hypertension	0.000136	0.000522	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ADRBK1—hypertension	0.000135	0.00052	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—hypertension	0.000135	0.000517	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CNR1—hypertension	0.000134	0.000516	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NEDD4L—hypertension	0.000133	0.000509	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PGF—hypertension	0.000133	0.000509	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PPBP—hypertension	0.000133	0.000509	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR2B—hypertension	0.000133	0.000509	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—SST—hypertension	0.000132	0.000507	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EDNRA—hypertension	0.000132	0.000507	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—hypertension	0.000132	0.000506	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—DRD3—hypertension	0.000132	0.000505	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ADRB1—hypertension	0.000132	0.000505	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR7—hypertension	0.000131	0.000503	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—DRD2—hypertension	0.000131	0.000503	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NFATC2—hypertension	0.00013	0.0005	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LEPR—hypertension	0.00013	0.0005	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—GCG—hypertension	0.00013	0.000498	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—POMC—hypertension	0.00013	0.000498	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ADRA2A—hypertension	0.000129	0.000497	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GHRL—hypertension	0.000129	0.000495	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CDKN1A—hypertension	0.000128	0.00049	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—PTEN—hypertension	0.000127	0.000489	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CALCA—hypertension	0.000127	0.000488	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCL2—hypertension	0.000127	0.000487	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—MAPK8—hypertension	0.000125	0.000478	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDE4A—hypertension	0.000125	0.000478	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ATP2A3—hypertension	0.000125	0.000478	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—KNG1—hypertension	0.000125	0.000478	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—BDKRB2—hypertension	0.000124	0.000477	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AGTR1—hypertension	0.000124	0.000475	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ADRBK1—hypertension	0.000123	0.000472	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CNR1—hypertension	0.000122	0.000468	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—INHBA—hypertension	0.000121	0.000465	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADRA1A—hypertension	0.000121	0.000465	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ARHGDIA—hypertension	0.000121	0.000465	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL10—hypertension	0.000121	0.000464	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CALM2—hypertension	0.000121	0.000463	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ROCK2—hypertension	0.00012	0.000459	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HTR7—hypertension	0.000119	0.000457	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—DRD2—hypertension	0.000119	0.000457	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—SRC—hypertension	0.000118	0.000453	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GCG—hypertension	0.000118	0.000452	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ADRB2—hypertension	0.000118	0.000451	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AVPR1A—hypertension	0.000117	0.000448	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CYSLTR1—hypertension	0.000117	0.000448	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCE—hypertension	0.000116	0.000445	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LHB—hypertension	0.000115	0.000442	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—TP53—hypertension	0.000115	0.000442	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—VAV3—hypertension	0.000115	0.00044	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RGS2—hypertension	0.000114	0.000437	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GAL—hypertension	0.000114	0.000437	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—KNG1—hypertension	0.000113	0.000434	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CMA1—hypertension	0.000113	0.000432	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CRHR1—hypertension	0.000113	0.000432	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—UTS2—hypertension	0.000113	0.000432	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GNRH1—hypertension	0.000113	0.000432	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VIP—hypertension	0.000113	0.000432	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TRH—hypertension	0.000113	0.000432	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—AGTR1—hypertension	0.000113	0.000431	CbGpPWpGaD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	0.000112	0.000155	CcSEcCtD
Regadenoson—Hypersensitivity—Clonidine—hypertension	0.000112	0.000155	CcSEcCtD
Regadenoson—Abdominal pain—Captopril—hypertension	0.000112	0.000155	CcSEcCtD
Regadenoson—Headache—Carvedilol—hypertension	0.000112	0.000155	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—GNB3—hypertension	0.000112	0.000429	CbGpPWpGaD
Regadenoson—Discomfort—Timolol—hypertension	0.000112	0.000154	CcSEcCtD
Regadenoson—Rash—Doxazosin—hypertension	0.000112	0.000154	CcSEcCtD
Regadenoson—Dermatitis—Doxazosin—hypertension	0.000111	0.000154	CcSEcCtD
Regadenoson—Gastrointestinal pain—Hydrochlorothiazide—hypertension	0.000111	0.000154	CcSEcCtD
Regadenoson—Vomiting—Fosinopril—hypertension	0.000111	0.000154	CcSEcCtD
Regadenoson—Malaise—Lisinopril—hypertension	0.000111	0.000154	CcSEcCtD
Regadenoson—Nausea—Propranolol—hypertension	0.000111	0.000153	CcSEcCtD
Regadenoson—Anaphylactic shock—Ramipril—hypertension	0.000111	0.000153	CcSEcCtD
Regadenoson—Headache—Doxazosin—hypertension	0.000111	0.000153	CcSEcCtD
Regadenoson—Pain—Losartan—hypertension	0.000111	0.000153	CcSEcCtD
Regadenoson—Syncope—Lisinopril—hypertension	0.00011	0.000153	CcSEcCtD
Regadenoson—Vomiting—Eplerenone—hypertension	0.00011	0.000153	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—AVP—hypertension	0.00011	0.000423	CbGpPWpGaD
Regadenoson—Feeling abnormal—Furosemide—hypertension	0.00011	0.000153	CcSEcCtD
Regadenoson—Rash—Fosinopril—hypertension	0.00011	0.000152	CcSEcCtD
Regadenoson—Dermatitis—Fosinopril—hypertension	0.00011	0.000152	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL10—hypertension	0.00011	0.000422	CbGpPWpGaD
Regadenoson—Vomiting—Nifedipine—hypertension	0.00011	0.000152	CcSEcCtD
Regadenoson—Gastrointestinal pain—Furosemide—hypertension	0.00011	0.000151	CcSEcCtD
Regadenoson—Rash—Eplerenone—hypertension	0.00011	0.000151	CcSEcCtD
Regadenoson—Urticaria—Perindopril—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Headache—Fosinopril—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Hypersensitivity—Trandolapril—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Dermatitis—Eplerenone—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Diarrhoea—Valsartan—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Asthenia—Clonidine—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Feeling abnormal—Betaxolol—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—OXTR—hypertension	0.000109	0.000419	CbGpPWpGaD
Regadenoson—Vomiting—Verapamil—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Urticaria—Irbesartan—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Shock—Ramipril—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Hypersensitivity—Enalapril—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—GNAS—hypertension	0.000109	0.000418	CbGpPWpGaD
Regadenoson—Abdominal pain—Perindopril—hypertension	0.000109	0.000151	CcSEcCtD
Regadenoson—Palpitations—Lisinopril—hypertension	0.000109	0.00015	CcSEcCtD
Regadenoson—Diarrhoea—Olmesartan—hypertension	0.000109	0.00015	CcSEcCtD
Regadenoson—Headache—Eplerenone—hypertension	0.000109	0.00015	CcSEcCtD
Regadenoson—Rash—Nifedipine—hypertension	0.000109	0.00015	CcSEcCtD
Regadenoson—Nervous system disorder—Ramipril—hypertension	0.000109	0.00015	CcSEcCtD
Regadenoson—Dermatitis—Nifedipine—hypertension	0.000109	0.00015	CcSEcCtD
Regadenoson—Abdominal pain—Irbesartan—hypertension	0.000109	0.00015	CcSEcCtD
Regadenoson—Anaphylactic shock—Timolol—hypertension	0.000108	0.00015	CcSEcCtD
Regadenoson—Loss of consciousness—Lisinopril—hypertension	0.000108	0.00015	CcSEcCtD
Regadenoson—Rash—Verapamil—hypertension	0.000108	0.00015	CcSEcCtD
Regadenoson—Urticaria—Hydrochlorothiazide—hypertension	0.000108	0.00015	CcSEcCtD
Regadenoson—Tachycardia—Ramipril—hypertension	0.000108	0.00015	CcSEcCtD
Regadenoson—Dermatitis—Verapamil—hypertension	0.000108	0.00015	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CX3CR1—hypertension	0.000108	0.000415	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CASR—hypertension	0.000108	0.000415	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TRPC3—hypertension	0.000108	0.000415	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LRP2—hypertension	0.000108	0.000415	CbGpPWpGaD
Regadenoson—Headache—Nifedipine—hypertension	0.000108	0.000149	CcSEcCtD
Regadenoson—Abdominal pain—Hydrochlorothiazide—hypertension	0.000108	0.000149	CcSEcCtD
Regadenoson—Skin disorder—Ramipril—hypertension	0.000108	0.000149	CcSEcCtD
Regadenoson—Headache—Verapamil—hypertension	0.000108	0.000149	CcSEcCtD
Regadenoson—Hypersensitivity—Telmisartan—hypertension	0.000108	0.000149	CcSEcCtD
Regadenoson—Cough—Lisinopril—hypertension	0.000107	0.000149	CcSEcCtD
Regadenoson—Nausea—Diltiazem—hypertension	0.000107	0.000148	CcSEcCtD
Regadenoson—Nausea—Indapamide—hypertension	0.000107	0.000148	CcSEcCtD
Regadenoson—Hyperhidrosis—Ramipril—hypertension	0.000107	0.000148	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—ADRB2—hypertension	0.000107	0.000409	CbGpPWpGaD
Regadenoson—Asthenia—Trandolapril—hypertension	0.000107	0.000147	CcSEcCtD
Regadenoson—Shock—Timolol—hypertension	0.000107	0.000147	CcSEcCtD
Regadenoson—Feeling abnormal—Losartan—hypertension	0.000107	0.000147	CcSEcCtD
Regadenoson—Urticaria—Furosemide—hypertension	0.000106	0.000147	CcSEcCtD
Regadenoson—Nervous system disorder—Timolol—hypertension	0.000106	0.000147	CcSEcCtD
Regadenoson—Nausea—Carvedilol—hypertension	0.000106	0.000147	CcSEcCtD
Regadenoson—Asthenia—Enalapril—hypertension	0.000106	0.000147	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—HDAC6—hypertension	0.000106	0.000407	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CX3CL1—hypertension	0.000106	0.000407	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—BDKRB1—hypertension	0.000106	0.000407	CbGpPWpGaD
Regadenoson—Abdominal pain—Furosemide—hypertension	0.000106	0.000146	CcSEcCtD
Regadenoson—Gastrointestinal pain—Losartan—hypertension	0.000106	0.000146	CcSEcCtD
Regadenoson—Dizziness—Valsartan—hypertension	0.000106	0.000146	CcSEcCtD
Regadenoson—ADORA2A—Circadian rythm related genes—IL6—hypertension	0.000106	0.000405	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCE—hypertension	0.000105	0.000404	CbGpPWpGaD
Regadenoson—Urticaria—Betaxolol—hypertension	0.000105	0.000146	CcSEcCtD
Regadenoson—Skin disorder—Timolol—hypertension	0.000105	0.000146	CcSEcCtD
Regadenoson—Dizziness—Olmesartan—hypertension	0.000105	0.000145	CcSEcCtD
Regadenoson—Nausea—Doxazosin—hypertension	0.000105	0.000145	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—EDN1—hypertension	0.000105	0.000403	CbGpPWpGaD
Regadenoson—Chest pain—Lisinopril—hypertension	0.000105	0.000145	CcSEcCtD
Regadenoson—Arthralgia—Lisinopril—hypertension	0.000105	0.000145	CcSEcCtD
Regadenoson—Myalgia—Lisinopril—hypertension	0.000105	0.000145	CcSEcCtD
Regadenoson—Hyperhidrosis—Timolol—hypertension	0.000105	0.000145	CcSEcCtD
Regadenoson—Asthenia—Telmisartan—hypertension	0.000105	0.000145	CcSEcCtD
Regadenoson—Anxiety—Lisinopril—hypertension	0.000105	0.000144	CcSEcCtD
Regadenoson—Diarrhoea—Clonidine—hypertension	0.000104	0.000144	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CCL5—hypertension	0.000104	0.0004	CbGpPWpGaD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	0.000104	0.000144	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—VAV3—hypertension	0.000104	0.000399	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HSPG2—hypertension	0.000104	0.000399	CbGpPWpGaD
Regadenoson—Nausea—Fosinopril—hypertension	0.000104	0.000144	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—EGFR—hypertension	0.000104	0.000397	CbGpPWpGaD
Regadenoson—Discomfort—Lisinopril—hypertension	0.000104	0.000143	CcSEcCtD
Regadenoson—Hypotension—Ramipril—hypertension	0.000104	0.000143	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—hypertension	0.000104	0.000397	CbGpPWpGaD
Regadenoson—Nausea—Eplerenone—hypertension	0.000103	0.000143	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—GABBR1—hypertension	0.000103	0.000396	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKG1—hypertension	0.000103	0.000396	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PTH—hypertension	0.000103	0.000396	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDE4D—hypertension	0.000103	0.000396	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADM—hypertension	0.000103	0.000396	CbGpPWpGaD
Regadenoson—Urticaria—Losartan—hypertension	0.000103	0.000142	CcSEcCtD
Regadenoson—Nausea—Nifedipine—hypertension	0.000102	0.000142	CcSEcCtD
Regadenoson—Abdominal pain—Losartan—hypertension	0.000102	0.000141	CcSEcCtD
Regadenoson—Nausea—Verapamil—hypertension	0.000102	0.000141	CcSEcCtD
Regadenoson—Asthenia—Captopril—hypertension	0.000102	0.000141	CcSEcCtD
Regadenoson—Diarrhoea—Trandolapril—hypertension	0.000102	0.000141	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—GNB3—hypertension	0.000102	0.00039	CbGpPWpGaD
Regadenoson—Vomiting—Valsartan—hypertension	0.000102	0.00014	CcSEcCtD
Regadenoson—Diarrhoea—Enalapril—hypertension	0.000101	0.00014	CcSEcCtD
Regadenoson—Hypotension—Timolol—hypertension	0.000101	0.00014	CcSEcCtD
Regadenoson—Hypersensitivity—Irbesartan—hypertension	0.000101	0.00014	CcSEcCtD
Regadenoson—Vomiting—Olmesartan—hypertension	0.000101	0.00014	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Ramipril—hypertension	0.000101	0.00014	CcSEcCtD
Regadenoson—Rash—Valsartan—hypertension	0.000101	0.000139	CcSEcCtD
Regadenoson—Dizziness—Clonidine—hypertension	0.000101	0.000139	CcSEcCtD
Regadenoson—Dermatitis—Valsartan—hypertension	0.000101	0.000139	CcSEcCtD
Regadenoson—Anaphylactic shock—Lisinopril—hypertension	0.000101	0.000139	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—TACR1—hypertension	0.000101	0.000385	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CYBB—hypertension	0.000101	0.000385	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GLP1R—hypertension	0.000101	0.000385	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CXCL8—hypertension	0.0001	0.000385	CbGpPWpGaD
Regadenoson—Hypersensitivity—Hydrochlorothiazide—hypertension	0.0001	0.000139	CcSEcCtD
Regadenoson—Rash—Olmesartan—hypertension	0.0001	0.000139	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—AVP—hypertension	0.0001	0.000385	CbGpPWpGaD
Regadenoson—Insomnia—Ramipril—hypertension	0.0001	0.000139	CcSEcCtD
Regadenoson—Dermatitis—Olmesartan—hypertension	0.0001	0.000139	CcSEcCtD
Regadenoson—Headache—Valsartan—hypertension	0.0001	0.000138	CcSEcCtD
Regadenoson—Diarrhoea—Telmisartan—hypertension	9.99e-05	0.000138	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—ADCY5—hypertension	9.98e-05	0.000383	CbGpPWpGaD
Regadenoson—Headache—Olmesartan—hypertension	9.97e-05	0.000138	CcSEcCtD
Regadenoson—Paraesthesia—Ramipril—hypertension	9.95e-05	0.000138	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCG—hypertension	9.91e-05	0.00038	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—GNAS—hypertension	9.9e-05	0.00038	CbGpPWpGaD
Regadenoson—Shock—Lisinopril—hypertension	9.89e-05	0.000137	CcSEcCtD
Regadenoson—Asthenia—Perindopril—hypertension	9.89e-05	0.000137	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—HRH3—hypertension	9.89e-05	0.000379	CbGpPWpGaD
Regadenoson—Dyspnoea—Ramipril—hypertension	9.88e-05	0.000137	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Timolol—hypertension	9.87e-05	0.000136	CcSEcCtD
Regadenoson—Hypersensitivity—Furosemide—hypertension	9.87e-05	0.000136	CcSEcCtD
Regadenoson—Asthenia—Irbesartan—hypertension	9.86e-05	0.000136	CcSEcCtD
Regadenoson—Somnolence—Ramipril—hypertension	9.85e-05	0.000136	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCA—hypertension	9.84e-05	0.000377	CbGpPWpGaD
Regadenoson—Dizziness—Trandolapril—hypertension	9.83e-05	0.000136	CcSEcCtD
Regadenoson—Tachycardia—Lisinopril—hypertension	9.81e-05	0.000136	CcSEcCtD
Regadenoson—Insomnia—Timolol—hypertension	9.8e-05	0.000135	CcSEcCtD
Regadenoson—Dizziness—Enalapril—hypertension	9.79e-05	0.000135	CcSEcCtD
Regadenoson—Asthenia—Hydrochlorothiazide—hypertension	9.77e-05	0.000135	CcSEcCtD
Regadenoson—Hypersensitivity—Betaxolol—hypertension	9.77e-05	0.000135	CcSEcCtD
Regadenoson—Skin disorder—Lisinopril—hypertension	9.76e-05	0.000135	CcSEcCtD
Regadenoson—Paraesthesia—Timolol—hypertension	9.73e-05	0.000135	CcSEcCtD
Regadenoson—Hyperhidrosis—Lisinopril—hypertension	9.72e-05	0.000134	CcSEcCtD
Regadenoson—Diarrhoea—Captopril—hypertension	9.71e-05	0.000134	CcSEcCtD
Regadenoson—Vomiting—Clonidine—hypertension	9.69e-05	0.000134	CcSEcCtD
Regadenoson—Dyspnoea—Timolol—hypertension	9.66e-05	0.000134	CcSEcCtD
Regadenoson—Dizziness—Telmisartan—hypertension	9.65e-05	0.000133	CcSEcCtD
Regadenoson—Somnolence—Timolol—hypertension	9.63e-05	0.000133	CcSEcCtD
Regadenoson—Asthenia—Furosemide—hypertension	9.61e-05	0.000133	CcSEcCtD
Regadenoson—Rash—Clonidine—hypertension	9.61e-05	0.000133	CcSEcCtD
Regadenoson—Dermatitis—Clonidine—hypertension	9.6e-05	0.000133	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Ramipril—hypertension	9.57e-05	0.000132	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—hypertension	9.55e-05	0.000366	CbGpPWpGaD
Regadenoson—Headache—Clonidine—hypertension	9.54e-05	0.000132	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—EDN1—hypertension	9.54e-05	0.000366	CbGpPWpGaD
Regadenoson—Hypersensitivity—Losartan—hypertension	9.52e-05	0.000132	CcSEcCtD
Regadenoson—Asthenia—Betaxolol—hypertension	9.52e-05	0.000132	CcSEcCtD
Regadenoson—Nausea—Valsartan—hypertension	9.49e-05	0.000131	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CCL5—hypertension	9.46e-05	0.000363	CbGpPWpGaD
Regadenoson—Nausea—Olmesartan—hypertension	9.45e-05	0.000131	CcSEcCtD
Regadenoson—Vomiting—Trandolapril—hypertension	9.45e-05	0.000131	CcSEcCtD
Regadenoson—Diarrhoea—Perindopril—hypertension	9.43e-05	0.00013	CcSEcCtD
Regadenoson—Vomiting—Enalapril—hypertension	9.41e-05	0.00013	CcSEcCtD
Regadenoson—Diarrhoea—Irbesartan—hypertension	9.4e-05	0.00013	CcSEcCtD
Regadenoson—Hypotension—Lisinopril—hypertension	9.39e-05	0.00013	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR5—hypertension	9.39e-05	0.00036	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCD—hypertension	9.39e-05	0.00036	CbGpPWpGaD
Regadenoson—Dizziness—Captopril—hypertension	9.39e-05	0.00013	CcSEcCtD
Regadenoson—Rash—Trandolapril—hypertension	9.37e-05	0.00013	CcSEcCtD
Regadenoson—Dermatitis—Trandolapril—hypertension	9.36e-05	0.000129	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Timolol—hypertension	9.36e-05	0.000129	CcSEcCtD
Regadenoson—Rash—Enalapril—hypertension	9.33e-05	0.000129	CcSEcCtD
Regadenoson—Dermatitis—Enalapril—hypertension	9.32e-05	0.000129	CcSEcCtD
Regadenoson—Diarrhoea—Hydrochlorothiazide—hypertension	9.32e-05	0.000129	CcSEcCtD
Regadenoson—Headache—Trandolapril—hypertension	9.31e-05	0.000129	CcSEcCtD
Regadenoson—Vomiting—Telmisartan—hypertension	9.28e-05	0.000128	CcSEcCtD
Regadenoson—Asthenia—Losartan—hypertension	9.28e-05	0.000128	CcSEcCtD
Regadenoson—Headache—Enalapril—hypertension	9.27e-05	0.000128	CcSEcCtD
Regadenoson—Pain—Timolol—hypertension	9.27e-05	0.000128	CcSEcCtD
Regadenoson—Rash—Telmisartan—hypertension	9.2e-05	0.000127	CcSEcCtD
Regadenoson—Dermatitis—Telmisartan—hypertension	9.2e-05	0.000127	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—NCF2—hypertension	9.19e-05	0.000353	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HTR2A—hypertension	9.19e-05	0.000352	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—C3—hypertension	9.18e-05	0.000352	CbGpPWpGaD
Regadenoson—Diarrhoea—Furosemide—hypertension	9.17e-05	0.000127	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Lisinopril—hypertension	9.16e-05	0.000127	CcSEcCtD
Regadenoson—Headache—Telmisartan—hypertension	9.15e-05	0.000126	CcSEcCtD
Regadenoson—Feeling abnormal—Ramipril—hypertension	9.13e-05	0.000126	CcSEcCtD
Regadenoson—Dizziness—Perindopril—hypertension	9.11e-05	0.000126	CcSEcCtD
Regadenoson—Insomnia—Lisinopril—hypertension	9.09e-05	0.000126	CcSEcCtD
Regadenoson—Dizziness—Irbesartan—hypertension	9.08e-05	0.000126	CcSEcCtD
Regadenoson—Diarrhoea—Betaxolol—hypertension	9.08e-05	0.000125	CcSEcCtD
Regadenoson—Gastrointestinal pain—Ramipril—hypertension	9.06e-05	0.000125	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—ADCY5—hypertension	9.06e-05	0.000347	CbGpPWpGaD
Regadenoson—Nausea—Clonidine—hypertension	9.05e-05	0.000125	CcSEcCtD
Regadenoson—Paraesthesia—Lisinopril—hypertension	9.03e-05	0.000125	CcSEcCtD
Regadenoson—Vomiting—Captopril—hypertension	9.03e-05	0.000125	CcSEcCtD
Regadenoson—Dizziness—Hydrochlorothiazide—hypertension	9.01e-05	0.000125	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCG—hypertension	9e-05	0.000345	CbGpPWpGaD
Regadenoson—Dyspnoea—Lisinopril—hypertension	8.96e-05	0.000124	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—NPY—hypertension	8.96e-05	0.000344	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VWF—hypertension	8.96e-05	0.000344	CbGpPWpGaD
Regadenoson—Rash—Captopril—hypertension	8.95e-05	0.000124	CcSEcCtD
Regadenoson—Dermatitis—Captopril—hypertension	8.94e-05	0.000124	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCA—hypertension	8.94e-05	0.000343	CbGpPWpGaD
Regadenoson—Somnolence—Lisinopril—hypertension	8.94e-05	0.000124	CcSEcCtD
Regadenoson—Feeling abnormal—Timolol—hypertension	8.93e-05	0.000123	CcSEcCtD
Regadenoson—Headache—Captopril—hypertension	8.89e-05	0.000123	CcSEcCtD
Regadenoson—Gastrointestinal pain—Timolol—hypertension	8.86e-05	0.000122	CcSEcCtD
Regadenoson—Dizziness—Furosemide—hypertension	8.86e-05	0.000122	CcSEcCtD
Regadenoson—Diarrhoea—Losartan—hypertension	8.85e-05	0.000122	CcSEcCtD
Regadenoson—Nausea—Trandolapril—hypertension	8.83e-05	0.000122	CcSEcCtD
Regadenoson—Urticaria—Ramipril—hypertension	8.81e-05	0.000122	CcSEcCtD
Regadenoson—Nausea—Enalapril—hypertension	8.79e-05	0.000122	CcSEcCtD
Regadenoson—Dizziness—Betaxolol—hypertension	8.77e-05	0.000121	CcSEcCtD
Regadenoson—Vomiting—Perindopril—hypertension	8.76e-05	0.000121	CcSEcCtD
Regadenoson—Abdominal pain—Ramipril—hypertension	8.76e-05	0.000121	CcSEcCtD
Regadenoson—Vomiting—Irbesartan—hypertension	8.73e-05	0.000121	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—AGT—hypertension	8.72e-05	0.000334	CbGpPWpGaD
Regadenoson—Rash—Perindopril—hypertension	8.69e-05	0.00012	CcSEcCtD
Regadenoson—Dermatitis—Perindopril—hypertension	8.68e-05	0.00012	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Lisinopril—hypertension	8.68e-05	0.00012	CcSEcCtD
Regadenoson—Nausea—Telmisartan—hypertension	8.67e-05	0.00012	CcSEcCtD
Regadenoson—Vomiting—Hydrochlorothiazide—hypertension	8.66e-05	0.00012	CcSEcCtD
Regadenoson—Rash—Irbesartan—hypertension	8.66e-05	0.00012	CcSEcCtD
Regadenoson—Dermatitis—Irbesartan—hypertension	8.65e-05	0.00012	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—AGTR2—hypertension	8.64e-05	0.000331	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL2—hypertension	8.64e-05	0.000331	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—OXT—hypertension	8.64e-05	0.000331	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR1B—hypertension	8.64e-05	0.000331	CbGpPWpGaD
Regadenoson—Headache—Perindopril—hypertension	8.63e-05	0.000119	CcSEcCtD
Regadenoson—Urticaria—Timolol—hypertension	8.61e-05	0.000119	CcSEcCtD
Regadenoson—Headache—Irbesartan—hypertension	8.61e-05	0.000119	CcSEcCtD
Regadenoson—Pain—Lisinopril—hypertension	8.6e-05	0.000119	CcSEcCtD
Regadenoson—Rash—Hydrochlorothiazide—hypertension	8.59e-05	0.000119	CcSEcCtD
Regadenoson—Dermatitis—Hydrochlorothiazide—hypertension	8.58e-05	0.000119	CcSEcCtD
Regadenoson—Abdominal pain—Timolol—hypertension	8.57e-05	0.000118	CcSEcCtD
Regadenoson—Dizziness—Losartan—hypertension	8.55e-05	0.000118	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—TGFBR1—hypertension	8.55e-05	0.000328	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—F2R—hypertension	8.55e-05	0.000328	CbGpPWpGaD
Regadenoson—Headache—Hydrochlorothiazide—hypertension	8.54e-05	0.000118	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCD—hypertension	8.53e-05	0.000327	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR5—hypertension	8.53e-05	0.000327	CbGpPWpGaD
Regadenoson—Vomiting—Furosemide—hypertension	8.52e-05	0.000118	CcSEcCtD
Regadenoson—Rash—Furosemide—hypertension	8.45e-05	0.000117	CcSEcCtD
Regadenoson—Dermatitis—Furosemide—hypertension	8.44e-05	0.000117	CcSEcCtD
Regadenoson—Vomiting—Betaxolol—hypertension	8.43e-05	0.000117	CcSEcCtD
Regadenoson—Nausea—Captopril—hypertension	8.43e-05	0.000117	CcSEcCtD
Regadenoson—Headache—Furosemide—hypertension	8.39e-05	0.000116	CcSEcCtD
Regadenoson—Rash—Betaxolol—hypertension	8.36e-05	0.000116	CcSEcCtD
Regadenoson—Dermatitis—Betaxolol—hypertension	8.36e-05	0.000116	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—HTR2A—hypertension	8.34e-05	0.00032	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—C3—hypertension	8.33e-05	0.00032	CbGpPWpGaD
Regadenoson—Headache—Betaxolol—hypertension	8.31e-05	0.000115	CcSEcCtD
Regadenoson—Feeling abnormal—Lisinopril—hypertension	8.28e-05	0.000115	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—EDNRB—hypertension	8.28e-05	0.000317	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NCF1—hypertension	8.28e-05	0.000317	CbGpPWpGaD
Regadenoson—Gastrointestinal pain—Lisinopril—hypertension	8.22e-05	0.000114	CcSEcCtD
Regadenoson—Vomiting—Losartan—hypertension	8.22e-05	0.000114	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—TAC1—hypertension	8.19e-05	0.000314	CbGpPWpGaD
Regadenoson—Nausea—Perindopril—hypertension	8.19e-05	0.000113	CcSEcCtD
Regadenoson—Hypersensitivity—Ramipril—hypertension	8.17e-05	0.000113	CcSEcCtD
Regadenoson—Nausea—Irbesartan—hypertension	8.16e-05	0.000113	CcSEcCtD
Regadenoson—Rash—Losartan—hypertension	8.15e-05	0.000113	CcSEcCtD
Regadenoson—Dermatitis—Losartan—hypertension	8.14e-05	0.000113	CcSEcCtD
Regadenoson—Headache—Losartan—hypertension	8.1e-05	0.000112	CcSEcCtD
Regadenoson—Nausea—Hydrochlorothiazide—hypertension	8.09e-05	0.000112	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—F2—hypertension	8.06e-05	0.000309	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PRKCB—hypertension	8.06e-05	0.000309	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCR3—hypertension	8.04e-05	0.000308	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ANXA1—hypertension	8.04e-05	0.000308	CbGpPWpGaD
Regadenoson—Urticaria—Lisinopril—hypertension	7.99e-05	0.00011	CcSEcCtD
Regadenoson—Hypersensitivity—Timolol—hypertension	7.98e-05	0.00011	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—IL6—hypertension	7.96e-05	0.000305	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IKBKB—hypertension	7.96e-05	0.000305	CbGpPWpGaD
Regadenoson—Nausea—Furosemide—hypertension	7.96e-05	0.00011	CcSEcCtD
Regadenoson—Asthenia—Ramipril—hypertension	7.95e-05	0.00011	CcSEcCtD
Regadenoson—Abdominal pain—Lisinopril—hypertension	7.95e-05	0.00011	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—AGT—hypertension	7.92e-05	0.000304	CbGpPWpGaD
Regadenoson—Nausea—Betaxolol—hypertension	7.88e-05	0.000109	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—EDNRA—hypertension	7.82e-05	0.0003	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SST—hypertension	7.82e-05	0.0003	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CALM1—hypertension	7.78e-05	0.000299	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FLT1—hypertension	7.78e-05	0.000298	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CYBA—hypertension	7.78e-05	0.000298	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADRB1—hypertension	7.78e-05	0.000298	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—DRD3—hypertension	7.78e-05	0.000298	CbGpPWpGaD
Regadenoson—Asthenia—Timolol—hypertension	7.77e-05	0.000107	CcSEcCtD
Regadenoson—Nausea—Losartan—hypertension	7.68e-05	0.000106	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—ADRA2A—hypertension	7.65e-05	0.000293	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PLAT—hypertension	7.62e-05	0.000292	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GHRL—hypertension	7.62e-05	0.000292	CbGpPWpGaD
Regadenoson—Diarrhoea—Ramipril—hypertension	7.58e-05	0.000105	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CALCA—hypertension	7.52e-05	0.000289	CbGpPWpGaD
Regadenoson—Diarrhoea—Timolol—hypertension	7.41e-05	0.000102	CcSEcCtD
Regadenoson—Hypersensitivity—Lisinopril—hypertension	7.41e-05	0.000102	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—BDKRB2—hypertension	7.35e-05	0.000282	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—AKT1—hypertension	7.35e-05	0.000282	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—POMC—hypertension	7.34e-05	0.000281	CbGpPWpGaD
Regadenoson—Dizziness—Ramipril—hypertension	7.33e-05	0.000101	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PRKCB—hypertension	7.32e-05	0.000281	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—F2—hypertension	7.32e-05	0.000281	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADRBK1—hypertension	7.27e-05	0.000279	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CNR1—hypertension	7.21e-05	0.000277	CbGpPWpGaD
Regadenoson—Asthenia—Lisinopril—hypertension	7.21e-05	9.97e-05	CcSEcCtD
Regadenoson—Dizziness—Timolol—hypertension	7.17e-05	9.91e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CALM2—hypertension	7.14e-05	0.000274	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AKT2—hypertension	7.05e-05	0.000271	CbGpPWpGaD
Regadenoson—Vomiting—Ramipril—hypertension	7.05e-05	9.74e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—HTR7—hypertension	7.04e-05	0.00027	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—DRD2—hypertension	7.04e-05	0.00027	CbGpPWpGaD
Regadenoson—Rash—Ramipril—hypertension	6.99e-05	9.66e-05	CcSEcCtD
Regadenoson—Dermatitis—Ramipril—hypertension	6.98e-05	9.65e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PTPN1—hypertension	6.97e-05	0.000267	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GCG—hypertension	6.97e-05	0.000267	CbGpPWpGaD
Regadenoson—Headache—Ramipril—hypertension	6.94e-05	9.6e-05	CcSEcCtD
Regadenoson—Vomiting—Timolol—hypertension	6.89e-05	9.52e-05	CcSEcCtD
Regadenoson—Diarrhoea—Lisinopril—hypertension	6.88e-05	9.51e-05	CcSEcCtD
Regadenoson—Rash—Timolol—hypertension	6.83e-05	9.45e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—KL—hypertension	6.83e-05	0.000262	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOTCH2—hypertension	6.83e-05	0.000262	CbGpPWpGaD
Regadenoson—Dermatitis—Timolol—hypertension	6.83e-05	9.44e-05	CcSEcCtD
Regadenoson—Headache—Timolol—hypertension	6.79e-05	9.38e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—ITGAV—hypertension	6.71e-05	0.000257	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NGFR—hypertension	6.71e-05	0.000257	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—KNG1—hypertension	6.69e-05	0.000256	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—POMC—hypertension	6.66e-05	0.000256	CbGpPWpGaD
Regadenoson—Dizziness—Lisinopril—hypertension	6.65e-05	9.19e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PRL—hypertension	6.65e-05	0.000255	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AGTR1—hypertension	6.65e-05	0.000255	CbGpPWpGaD
Regadenoson—Nausea—Ramipril—hypertension	6.58e-05	9.1e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—STK11—hypertension	6.55e-05	0.000251	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HDAC1—hypertension	6.55e-05	0.000251	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL2—hypertension	6.52e-05	0.00025	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL10—hypertension	6.49e-05	0.000249	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PLG—hypertension	6.48e-05	0.000248	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—RHOA—hypertension	6.47e-05	0.000248	CbGpPWpGaD
Regadenoson—Nausea—Timolol—hypertension	6.44e-05	8.9e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—AKT2—hypertension	6.41e-05	0.000246	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PIK3R1—hypertension	6.4e-05	0.000245	CbGpPWpGaD
Regadenoson—Vomiting—Lisinopril—hypertension	6.39e-05	8.84e-05	CcSEcCtD
Regadenoson—Rash—Lisinopril—hypertension	6.34e-05	8.76e-05	CcSEcCtD
Regadenoson—Dermatitis—Lisinopril—hypertension	6.33e-05	8.75e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—ADRB2—hypertension	6.31e-05	0.000242	CbGpPWpGaD
Regadenoson—Headache—Lisinopril—hypertension	6.3e-05	8.71e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PRKCE—hypertension	6.23e-05	0.000239	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDGFA—hypertension	6.15e-05	0.000236	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VAV3—hypertension	6.15e-05	0.000236	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TGFBR2—hypertension	6.06e-05	0.000232	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GNB3—hypertension	6e-05	0.00023	CbGpPWpGaD
Regadenoson—Nausea—Lisinopril—hypertension	5.97e-05	8.25e-05	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—AVP—hypertension	5.92e-05	0.000227	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—RHOA—hypertension	5.87e-05	0.000225	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—GNAS—hypertension	5.85e-05	0.000224	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PIK3R1—hypertension	5.81e-05	0.000223	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOB—hypertension	5.73e-05	0.00022	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PTK2—hypertension	5.7e-05	0.000219	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL8—hypertension	5.68e-05	0.000218	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDN1—hypertension	5.63e-05	0.000216	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL5—hypertension	5.59e-05	0.000214	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LPL—hypertension	5.47e-05	0.00021	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—H2AFX—hypertension	5.43e-05	0.000208	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RPS6KB1—hypertension	5.42e-05	0.000208	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDGFRB—hypertension	5.42e-05	0.000208	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ADCY5—hypertension	5.35e-05	0.000205	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKCG—hypertension	5.32e-05	0.000204	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKCA—hypertension	5.28e-05	0.000202	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—ITGB3—hypertension	5.28e-05	0.000202	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—YWHAZ—hypertension	5.24e-05	0.000201	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NGF—hypertension	5.18e-05	0.000199	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SPP1—hypertension	5.18e-05	0.000199	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL8—hypertension	5.16e-05	0.000198	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCR5—hypertension	5.04e-05	0.000193	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKCD—hypertension	5.04e-05	0.000193	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HTR2A—hypertension	4.93e-05	0.000189	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—C3—hypertension	4.92e-05	0.000189	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDGFB—hypertension	4.79e-05	0.000184	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FGFR1—hypertension	4.77e-05	0.000183	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HIF1A—hypertension	4.69e-05	0.00018	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AGT—hypertension	4.68e-05	0.000179	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CALM1—hypertension	4.6e-05	0.000176	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOE—hypertension	4.58e-05	0.000176	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LEP—hypertension	4.58e-05	0.000176	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CAV1—hypertension	4.54e-05	0.000174	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOA1—hypertension	4.53e-05	0.000174	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—KDR—hypertension	4.49e-05	0.000172	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PRKCB—hypertension	4.32e-05	0.000166	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FN1—hypertension	4.32e-05	0.000166	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—F2—hypertension	4.32e-05	0.000166	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOTCH1—hypertension	4.23e-05	0.000162	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—POMC—hypertension	3.94e-05	0.000151	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—INS—hypertension	3.91e-05	0.00015	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL2—hypertension	3.85e-05	0.000148	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IGF1—hypertension	3.79e-05	0.000145	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AKT2—hypertension	3.78e-05	0.000145	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EGFR—hypertension	3.77e-05	0.000144	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SERPINE1—hypertension	3.6e-05	0.000138	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FGF2—hypertension	3.48e-05	0.000133	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RHOA—hypertension	3.47e-05	0.000133	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PIK3R1—hypertension	3.43e-05	0.000132	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOS3—hypertension	3.43e-05	0.000132	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RELA—hypertension	3.23e-05	0.000124	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MTOR—hypertension	3.17e-05	0.000122	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL8—hypertension	3.05e-05	0.000117	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AKT1—hypertension	2.94e-05	0.000113	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6—hypertension	2.9e-05	0.000111	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MMP9—hypertension	2.75e-05	0.000106	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CDKN1A—hypertension	2.74e-05	0.000105	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PTEN—hypertension	2.74e-05	0.000105	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MAPK8—hypertension	2.68e-05	0.000103	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—AKT1—hypertension	2.67e-05	0.000102	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EP300—hypertension	2.61e-05	0.0001	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SRC—hypertension	2.54e-05	9.74e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VEGFA—hypertension	2.47e-05	9.49e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MYC—hypertension	2.28e-05	8.73e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TGFB1—hypertension	2.27e-05	8.71e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EGFR—hypertension	2.23e-05	8.54e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TP53—hypertension	1.87e-05	7.17e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6—hypertension	1.71e-05	6.56e-05	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AKT1—hypertension	1.58e-05	6.05e-05	CbGpPWpGaD
